Prestige Consumer Healthcare Inc
NYSE:PBH

Watchlist Manager
Prestige Consumer Healthcare Inc Logo
Prestige Consumer Healthcare Inc
NYSE:PBH
Watchlist
Price: 86.04 USD 1.22% Market Closed
Market Cap: 4.3B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+66%
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

PBH Price Targets Summary
Prestige Consumer Healthcare Inc

Wall Street analysts forecast PBH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PBH is 93.33 USD with a low forecast of 81.81 USD and a high forecast of 109.2 USD.

PBH Lowest Forecast
Wall Street Target
81.81 USD
5% Downside
PBH Average Forecast
Wall Street Target
93.33 USD
8% Upside
PBH Highest Forecast
Wall Street Target
109.2 USD
27% Upside
Lowest
Price Target
81.81 USD
5% Downside
Average
Price Target
93.33 USD
8% Upside
Highest
Price Target
109.2 USD
27% Upside
Prestige Consumer Healthcare Inc Competitors:
Price Targets
185750
Chong Kun Dang Pharmaceutical Corp
57% Upside
NEULANDLAB
Neuland Laboratories Ltd
47% Upside
A
ABBOTINDIA
Abbott India Ltd
9% Upside
Z
603456
Zhejiang Jiuzhou Pharmaceutical Co Ltd
36% Upside
185750
Chong Kun Dang Pharmaceutical Corp
57% Upside
NEULANDLAB
Neuland Laboratories Ltd
47% Upside
A
ABBOTINDIA
Abbott India Ltd
9% Upside
Z
603456
Zhejiang Jiuzhou Pharmaceutical Co Ltd
36% Upside
600195
China Animal Husbandry Industry Co Ltd
20% Upside
C
300765
CSPC Innovation Pharmaceutical Co Ltd
16% Upside
000999
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
32% Upside
M
4016
Middle East Pharmaceutical Industries Company SJSC
10% Upside

Revenue
Forecast

Revenue Estimate
Prestige Consumer Healthcare Inc

For the last 8 years the compound annual growth rate for Prestige Consumer Healthcare Inc's revenue is 4%. The projected CAGR for the next 4 years is 2%.

4%
Past Growth
2%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Prestige Consumer Healthcare Inc

For the last 8 years the compound annual growth rate for Prestige Consumer Healthcare Inc's operating income is 3%. The projected CAGR for the next 4 years is 3%.

3%
Past Growth
3%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Prestige Consumer Healthcare Inc

For the last 8 years the compound annual growth rate for Prestige Consumer Healthcare Inc's net income is 10%. The projected CAGR for the next 4 years is 6%.

10%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

See Also

Summary
PBH intrinsic value, competitors valuation, and company profile.
DCF Valuation
PBH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PBH stock valuation using valuation multiples.
Wall Street Estimates
PBH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PBH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PBH's stock price target?
Price Target
93.33 USD

According to Wall Street analysts, the average 1-year price target for PBH is 93.33 USD with a low forecast of 81.81 USD and a high forecast of 109.2 USD.

What is Prestige Consumer Healthcare Inc's Revenue forecast?
Projected CAGR
2%

For the last 8 years the compound annual growth rate for Prestige Consumer Healthcare Inc's revenue is 4%. The projected CAGR for the next 4 years is 2%.

What is Prestige Consumer Healthcare Inc's Operating Income forecast?
Projected CAGR
3%

For the last 8 years the compound annual growth rate for Prestige Consumer Healthcare Inc's operating income is 3%. The projected CAGR for the next 4 years is 3%.

What is Prestige Consumer Healthcare Inc's Net Income forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Prestige Consumer Healthcare Inc's net income is 10%. The projected CAGR for the next 4 years is 6%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 242,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.